revenu pre-announc servic stock help perform
still better origin fear oper disciplin continu exceed expect
durat magnitud pandem remain hard size believ
updat forecast appropri captur near term risk notabl recent model updat
remain larg unchang
revenu grew y/i consist pre-announc
line origin forecast addit better conserv
post-covid forecast howev note consum stock better
expect servic revenu account
upsid rel forecast thu held better origin fear howev
wasnt quit robust seem time pre-announc
gross margin better expect mix
believ continu oper improv also contribut addit oper
spend prior forecast time also
pullback spend non-gaap basi led ep far better
expect given time revenu pressur like made tougher nimbl
expens manag
consist pre-announc link still hold provid guidanc
howev compani indic april consum volum
clinic custom run level consum
research custom volum run level appear
manag see sign improv recent consum still expect
sequenti growth instrument gross margin expect declin
y/i q/q opex expect flat y/i
made best effort updat forecast consist manag
commentari beyond assum sequenti recoveri consum revenu
year-end expect annual consum revenu instrument declin rel
expect recoveri instrument placement forecast
place instrument origin forecast
gener assum placement pull close
origin expect also forecast similar level opex rel
continu believ ep could approxim believ price target
justifi basi also base refin dcf recogn far
recent close price said believ appropri next step us
await detail magnitud durat headwind tri
better assess potenti not-model sourc upsid look ahead
pleas see page report import disclosur
well posit maintain leadership expand high end genet
arm dealer elimin barrier sequenc becom increasingli use
clinic adjac market increasingli drive oper leverag bottom
 believ factor continu translat hsd revenu earn
nextseq key growth driver
continu evolv favor
new instruments/kit surpris
sourc revenu
expand use sequenc increas
becom much favor
popgen program drive upsid
novaseq unabl catalyz
strength nextseq placement
concern build oper leverag
slow materi
hiseq bigger expect headwind
leader genet tool segment tool diagnost market segment
compani broad portfolio system consum analysi tool design
simplifi genet analysi address rang genom complex price point
throughput enabl research select best solut scientif challeng
market leader next gener sequenc increasingli focus popgen
initi act arm dealer emerg oncolog clinical/transl
cowen compani
cowen vs consensu mm except guidanc higher y/i due favour revenu mixoper guidanc revenu metric mm except metricstot sequenc statement mm except growth per count margin gross margin higher y/i due favour revenu mix also increas fix cost leverag ramp stock volumesproduct revenu better expect importantli instrument better forecast beat larg function consum growth due stock revenu better forecast consum revenu forecast beat larg function consum growth consum stock servic revenu forecast larg due expect season dtc follow thruthi ahead forecast cowen
compani report cowen compani
yr cagrcomments/guidancetot guidanc growth withdrawnrevenu product classproduct inst servic incl nextbio revenu geographyamerica system placement low partial off-set consum stock revenue expect declineeurop middl east system placement low partial off-set consum stock revenue expect declinegreat smallest dollar declin expect growth y/i middl east revenu growth salesproduct middl east grow high teen primarili due clinic sequencingasia sequenc guid y/i sequenc consum growth y/i growth revenu growth total revenu growth microarray expect declin y/i revenu growth total revenu growth wors anticip apr expect mid-teen y/i comment purchas instrument lh array system strength partial function scale lhcowen comment manag indic largerli consum littl mainten believ largerli ancestri com cowen comment relat instrument maint contract remaind nipt popgen core ip/licens oncolog collabor also front ivd licens record note gel account servic revenu mostli manag comment volum run close research clinic sequenc run respect cowen
compani report thomson eikon cowen compani
mm except per share guidancenet guidanc growth withdrawnreport favor revenu mix led increas gm gener oper opex reduc reduc labor spend travel restrict etc impact growth reset non-oper interest loss attribut nci add earn per guidanc withdrawnshar roughli flat gross op cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk includ limit greater-than-expect reduct academ
govern research fund competit commerci avail potenti
disrupt technolog price pressur caus competit increas demand
lower-pr instrument run-tim cost neg regulatori dynam
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank
servic past month
cowen compani llc and/or affili expect receiv intend seek compens invest bank servic next month
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc april et dissemin april et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
